Results 151 to 160 of about 12,929 (204)

Dysregulated Peroxiredoxins in Bladder Cancer Are Associated With an Altered Tumour Immune Microenvironment. [PDF]

J Cell Mol Med
Wallerson J, Rostampour S, Teng S, Kidane D.   +3 more
europepmc   +1 more source

DNA methylation-mediated silencing of HNF1B promotes bladder cancer progression. [PDF]

Clin Epigenetics
Luo C, Kuang X, Dai Y, Cai Z, Hu J, Liu P, Chen J.   +6 more
europepmc   +1 more source

Hypoxia-Induced TGFBI Promotes Bladder Cancer Progression by Creating a Stemness Regulation Loop through Stabilizing the Disulfide Bonds of GDF15. [PDF]

Research (Wash D C)
Zhang G, Wang L, Zhao G, Huang Y, Yu J, Cao Y, Sun R, Li Q, Wei Z, Jiang Y, Peng Y, He W, Xie Y, Liu J.   +13 more
europepmc   +1 more source

Imagine the Duture: An Ex Post Facto Analysis of the 53rd BLCA Biennial Conference

North Carolina Libraries, 1999
openaire   +2 more sources

Exploring the toxicological impact of N-nitrosodimethylamine (NDMA) exposure on bladder urothelial carcinoma (BLCA) through network toxicology, machine learning, and multi-dimensional bioinformatics analysis. [PDF]

Discov Oncol
Shi Z, Yang X, Liu Y, Gao Y, Liu J, Wang L, Wang X.   +6 more
europepmc   +1 more source

Glycolysis-related genes for bladder cancer: A Mendelian randomization analysis. [PDF]

Biochem Biophys Rep
Hong X, Wang G, Hong T, Liu X, Lin S, Liu G, Lin W, Zhang Y.   +7 more
europepmc   +1 more source

Integration of bulk and single-cell transcriptomic sequencing reveals the neutrophil heterogeneity in bladder cancer and establishes a prognostic model. [PDF]

Discov Oncol
Song YX, Xia XL, Wu ZM, Yao Y, Liang JY, Guo SJ, Yao K, Chang H.   +7 more
europepmc   +1 more source

Integrative analysis of the PSMA family identifies PSMA6 as an adverse prognostic biomarker promoting bladder cancer cell proliferation. [PDF]

Int J Med Sci
Huang Z, Cao X, Yan Y, Li H, Shen B, Wang T.   +5 more
europepmc   +1 more source

Development and validation of a gemcitabine sensitivity-related long noncoding RNA signature for predicting the prognosis and subtypes of bladder cancer. [PDF]

Transl Androl Urol
Liu J, Tang X, Cui Y, Yang X, Yang Y, Du P.   +5 more
europepmc   +1 more source

Development and validation of a novel senescence-associated gene signature for prediction of survival and endocrine-disrupting chemicals in bladder cancer. [PDF]

Discov Oncol
Qin M, Xie G, Xie H, Lin B, Dai Z, Cheng Z, Wang L, Zhang J, Wang F.   +8 more
europepmc   +1 more source